- Home
- ABOS vs ALPX Comparison
ABOS vs ALPX Comparison
Compare ABOS & ALPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
BUY
Current Price
$1.68
Company Overview
Basic Information| Metric | ABOS | ALPX |
|---|---|---|
| Founded | 1996 | 2026 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 147.5M | 146.3M |
| IPO Year | 2021 | 2026 |
Fundamental Metrics
Financial Performance| Metric | ABOS | ALPX |
|---|---|---|
| Price | $1.68 | $9.97 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $7.60 | N/A |
| AVG Volume (30 Days) | ★ 547.5K | 52.8K |
| Earning Date | 11-11-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.50 | $9.85 |
| 52 Week High | $3.60 | $9.97 |
Technical Indicators
Market Signals| Indicator | ABOS | ALPX |
|---|---|---|
| Relative Strength Index (RSI) | 26.69 | 69.42 |
| Support Level | $1.67 | $9.94 |
| Resistance Level | $2.77 | N/A |
| Average True Range (ATR) | 0.14 | 0.00 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 10.00 | 100.00 |
Price Performance
Historical Comparison ABOS
ALPX
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.
About ALPX Alpex Acquisition Corporation Class A Ordinary Shares
Alpex Acquisition Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities.